Today: 19 March 2026
Subscribe
Browse Category

Stock Market 22 December 2025

Boeing Stock News Today (Dec. 22, 2025): BA Price Action, Fresh Headlines, Analyst Forecasts, and the 2026 Outlook

Boeing Stock News Today (Dec. 22, 2025): BA Price Action, Fresh Headlines, Analyst Forecasts, and the 2026 Outlook

Boeing shares rose about 1.1% to $216.39 on December 22, 2025, after trading between $214.22 and $217.09. The move comes as the company reports supplier defect reductions and seeks an FAA waiver to continue selling 777F freighters. An Air India Boeing 777 incident is under investigation but did not involve injuries. Year-to-date, Boeing stock is up roughly 22%.
22 December 2025
·
Infosys Stock (INFY) Jumps After ADR Whiplash and McCamish Settlement Update: Latest News, Forecasts, and What’s Next (Dec. 22, 2025)

Infosys Stock (INFY) Jumps After ADR Whiplash and McCamish Settlement Update: Latest News, Forecasts, and What’s Next (Dec. 22, 2025)

Infosys shares rose in India on December 22, 2025, after the company addressed a sharp, unexplained spike in its U.S.-traded ADRs that triggered two trading halts on the NYSE. Infosys stated no material events required disclosure and attributed the volatility to market mechanics, not business fundamentals. The move followed a court update involving its U.S. subsidiary.
22 December 2025
····
Chevron Stock (CVX) Climbs on Venezuela Supply Risks: Latest News, Forecasts and Outlook (Dec. 22, 2025)

Chevron Stock (CVX) Climbs on Venezuela Supply Risks: Latest News, Forecasts and Outlook (Dec. 22, 2025)

Chevron shares rose about 1.6% to $150 midday Monday, helping drive the Dow higher as oil prices climbed on Venezuela supply concerns. Reuters reported Chevron exported a 500,000-barrel Venezuelan oil cargo to the U.S. Sunday, with deliveries reportedly uninterrupted despite tanker slowdowns and operational issues in Venezuela.
22 December 2025
···
Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

Edgewise Therapeutics shares swung between $27.77 and $21.18 on Dec. 22, closing at $21.29 with volume over one million. The volatility followed a 20.8% surge on Dec. 19 and mixed analyst commentary, including JPMorgan raising its price target to $34 despite concerns over a $40.67 million quarterly loss.
22 December 2025
··
Insmed (INSM) Stock News Today: Nasdaq‑100 Addition, Brensocatib Setback, and Updated Analyst Forecasts (Dec. 22, 2025)

Insmed (INSM) Stock News Today: Nasdaq‑100 Addition, Brensocatib Setback, and Updated Analyst Forecasts (Dec. 22, 2025)

Insmed joined the Nasdaq-100 Index on December 22, 2025, boosting its stock visibility. Shares traded at $177.86, up 1.7%, after recent swings triggered by a failed Phase 2b trial for brensocatib in chronic rhinosinusitis, which led the company to end that program. Insmed also acquired INS1148, a Phase 2–ready monoclonal antibody, for $40 million upfront.
22 December 2025
·
Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025)

Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025)

Twist Bioscience shares rose about 5.4% to $34.26 midday Dec. 22, 2025, after new licensing deals and product expansions. The stock remains down roughly 26% year-to-date despite the rally. Recent catalysts include a licensing agreement with Aptamer Group for hot-start PCR and NGS products and continued integration with Element Biosciences’ AVITI system. TWST’s 52-week range spans $23.30 to $55.33.
22 December 2025
··
Sunrun Stock (NASDAQ: RUN) Jumps on Dec. 22, 2025: Tax-Credit Deadline, Analyst Targets, and the NRG Partnership in Focus

Sunrun Stock (NASDAQ: RUN) Jumps on Dec. 22, 2025: Tax-Credit Deadline, Analyst Targets, and the NRG Partnership in Focus

Sunrun shares jumped about 8% to near $19.80 by early afternoon Dec. 22, following a prior close of $18.26. The move comes as investors react to the looming end of the U.S. residential solar tax credit after Dec. 31, 2025, new analyst forecasts, and Sunrun’s Texas grid partnership with NRG. The IRS confirmed the credit expires for installations finished after the deadline.
22 December 2025
···
US Stock Market Today (Dec. 22, 2025, 1:36 p.m. ET): S&P 500, Dow and Nasdaq Rise as AI Stocks Rebound and Commodities Jump

US Stock Market Today (Dec. 22, 2025, 1:36 p.m. ET): S&P 500, Dow and Nasdaq Rise as AI Stocks Rebound and Commodities Jump

U.S. stocks rose early Monday, with the S&P 500 up 0.67% and the Nasdaq gaining 0.61% by 1:36 p.m. ET. Tesla hit a record high after a court reinstated Elon Musk’s 2018 pay package. Nvidia climbed as it prepared to ship H200 chips to China and lawmakers pressed for export details. Oil and gold prices advanced, boosting energy and materials shares.
22 December 2025
····
Dow Jones Today (Dec. 22, 2025): DJIA Near 48,410 at 1:35 PM ET as AI-Led Rally Lifts Stocks Ahead of Key U.S. Data

Dow Jones Today (Dec. 22, 2025): DJIA Near 48,410 at 1:35 PM ET as AI-Led Rally Lifts Stocks Ahead of Key U.S. Data

The Dow Jones Industrial Average climbed 0.6% to around 48,414 in early afternoon trading Monday, lifted by gains in technology and AI-related stocks such as Nvidia and Micron. Chevron and Merck contributed significantly to the index’s rise, while Nike lagged. The S&P 500 and Nasdaq also advanced about 0.6%. Trading volumes remained light ahead of the holiday.
22 December 2025
···
Viasat (VSAT) Stock Today: Price Jumps as ViaSat-3 Expansion, Ka-Band Defense Network, and Analyst Forecasts Shape 2026 Outlook (Dec. 22, 2025)

Viasat (VSAT) Stock Today: Price Jumps as ViaSat-3 Expansion, Ka-Band Defense Network, and Analyst Forecasts Shape 2026 Outlook (Dec. 22, 2025)

Viasat shares rose about 7% to $36.16 by midday Monday, Dec. 22, 2025, after the company released a year-in-review update. The recap highlighted the November launch of ViaSat-3 F2, plans for expanded capacity in 2026, and over 2,000 maritime orders for its NexusWave system. The stock traded between the mid-$34s and mid-$36s during the session.
22 December 2025
····
Planet Labs Stock (PL) Surges on Dec. 22, 2025: Record Revenue, Raised FY2026 Outlook, Analyst Targets, and What Comes Next

Planet Labs Stock (PL) Surges on Dec. 22, 2025: Record Revenue, Raised FY2026 Outlook, Analyst Targets, and What Comes Next

Planet Labs shares surged above $20 on December 22, 2025, after reporting record fiscal Q3 revenue of $81.3 million, up 33% year over year. Contract backlog jumped to $734 million, a 216% increase, and adjusted EBITDA turned positive at $5.6 million. The stock hit intraday highs of $20.70 with heavy trading volume. Planet raised full-year 2026 revenue guidance to as much as $301 million.
22 December 2025
··
Exzeo Group (NYSE: XZO) Stock News, Forecasts and Analysis for Dec. 22, 2025: Shares Hit a New High as Wall Street Coverage Builds

Exzeo Group (NYSE: XZO) Stock News, Forecasts and Analysis for Dec. 22, 2025: Shares Hit a New High as Wall Street Coverage Builds

Exzeo Group shares hit a new 52-week high of $23.50 on Dec. 22, 2025, before trading around $22.05, up about 6% from the prior close. The move follows strong Q3 results, new operating targets, and analyst coverage after its November IPO. Exzeo reported 90% revenue growth to $55.2 million and net income of $21.2 million for the quarter. Parent HCI Group retains an 81.5% stake.
22 December 2025
·
UnitedHealth Group (UNH) Stock News, Forecasts and Analysis for Dec. 22, 2025: Independent Reviews, DOJ Scrutiny, and 2026 Guidance in Focus

UnitedHealth Group (UNH) Stock News, Forecasts and Analysis for Dec. 22, 2025: Independent Reviews, DOJ Scrutiny, and 2026 Guidance in Focus

UnitedHealth Group shares traded near $325.48 on Dec. 22, down slightly from the previous close. The company released initial findings from independent reviews of its Medicare Advantage, care management, and Optum Rx operations, citing broadly sound practices but highlighting areas for improved oversight. UnitedHealth plans to complete most recommended changes by the end of 2025.
22 December 2025
·
T-Mobile US (TMUS) Stock News Today, Dec. 22, 2025: Bernstein Holds Neutral as SoftBank Stake Sales and 2026 Buyback Plan Shape the Outlook

T-Mobile US (TMUS) Stock News Today, Dec. 22, 2025: Bernstein Holds Neutral as SoftBank Stake Sales and 2026 Buyback Plan Shape the Outlook

T-Mobile shares traded near $195 midday Monday, down slightly, as SoftBank sold $4.8 billion of its stake to help fund a $22.5 billion OpenAI commitment, Reuters reported. The company recently authorized a $14.6 billion shareholder return program and will pay a $1.02 quarterly dividend in March. Bernstein reiterated a Neutral rating with a $265 target. Analyst consensus remains “Buy” with an average target of $262.
22 December 2025
·
Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

Warner Bros. Discovery shares rose Monday, closing near $28.70, after Paramount Skydance amended its $30-per-share hostile offer by adding a $40.4 billion personal guarantee from Larry Ellison. Netflix also revealed new financing moves for its agreed deal with WBD assets. Paramount extended its tender offer to January 21, 2026. Only 397,252 shares had been tendered as of December 19.
22 December 2025
··
Lululemon Stock (LULU) Today: Elliott’s $1B Stake, CEO Shake-Up, New 2026 Expansion—and What Wall Street Forecasts Next (Dec. 22, 2025)

Lululemon Stock (LULU) Today: Elliott’s $1B Stake, CEO Shake-Up, New 2026 Expansion—and What Wall Street Forecasts Next (Dec. 22, 2025)

Lululemon shares traded near $211 on Dec. 22, up 0.8%, as investors reacted to CEO Calvin McDonald’s planned departure and news of Elliott Management’s $1 billion-plus stake. Meghan Frank and André Maestrini will serve as interim co-CEOs starting Jan. 31. The company also announced expansion into six new international markets in 2026.
22 December 2025
··
Polestar Automotive Holding (PSNY) Stock Jumps After New Funding: Today’s News, Forecasts, and Analyst Views (Dec. 22, 2025)

Polestar Automotive Holding (PSNY) Stock Jumps After New Funding: Today’s News, Forecasts, and Analyst Views (Dec. 22, 2025)

Polestar shares rose nearly 11% to $14.18 by midday Monday after announcing a $300 million equity investment from BBVA and Natixis and a $300 million debt-to-equity swap by Geely. The new shares will be priced at $19.34 each, with no single institution holding over 10%. The deal includes put options with Geely and is expected to close by Dec. 23, 2025.
22 December 2025
··
Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics agreed to be acquired in an $8.4 billion all-cash deal, with shareholders set to receive $24.55 per share. The stock traded near $24.10 on December 22, below the offer price as investors weighed closing risk. Permira and Warburg Pincus, previous owners, are leading the buyout. The deal is expected to close in the first half of 2026, pending approvals.
22 December 2025
··
1 … 822 823 824 825 826 … 1,354

Stock Market Today

  • Avino Silver & Gold Mines Shares Surge 240.9%, But Valuation Raises Concerns
    March 19, 2026, 3:54 AM EDT. Avino Silver & Gold Mines (TSX:ASM) shares surged 240.9% over the past year, reaching US$8.66 before recent declines. Despite impressive returns, the stock fell 16.9% last week and 35% over 30 days amid volatile market sentiment. Our Discounted Cash Flow (DCF) analysis estimates the intrinsic value at around US$1.15 per share, suggesting the stock is overvalued by approximately 656%. The P/E ratio examination remains incomplete but implies the market may be pricing in aggressive growth. Investors should carefully weigh operational risks, funding challenges, and project pipelines given the stark valuation disparities. Avino's valuation score stands at 0/6, signaling red flags despite the strong share price momentum.
Go toTop